Phenotypical and functional characterizations of ex vivo manipulated cd34± progenitors from steady state and mobilized peripheral blood

L. Humeau, R. Namikawa, F. Bardin, C. Maroc, P. Manonni, M. G. Roncarolo, C. Chabannon

Research output: Contribution to journalArticle

Abstract

Cytokine mobilized peripheral blood progenitor cells are widely used lor iranspl.ini.iiu'n in cancer patients because of easy collection and rapid hématologie reconstitution These cells may be appropriate targets for gene transfer. Therefore, We investigated the effects of ex vivo manipulation on hematopoietic reconstitution potential of these cells. Immunoselected CD34± progenitors isolated from steady-state (ssCD34±) or G-CSF mobilized (mCD34±) peripheral blood were cultured for 5 days: 2-day liquid culture followed by 3-day coculture on A7.21, a rnurine fibroblast layer, in the presence of 10% PCS, 1L-3, IL-6, GM-CSF, and KL. Higher levels of expansion in CD34± cells were observed in ssCD34± than in mCD34± cells (4.6±3.3- vs. 2.2±1.3-fold). Hematopoietic reconstitution potentials of these ex vivo manipulated cells were evaluated using the SCID-hu mouse models implanted with human fetal bone marrow (BM) or thymus/liver. Human BM analyzed 4 weeks after injection of manipulated ssCD34± cells showed reconstitution in CD19± (0.6-98.8%), CD33± (2.8-99.3%) and CD34± progenitor (2.4-17%) cells (n=4); ihyinic grafts analyzed 6-8 weeks after injection also demonstrated high levels of T cells reconstitution (67.2-86.4%) (n=4). In contrast, only very low levels of reconstitution (

Original languageEnglish
Pages (from-to)879
Number of pages1
JournalExperimental Hematology
Volume25
Issue number8
Publication statusPublished - 1997

Fingerprint

Bone Marrow
Injections
SCID Mice
Granulocyte Colony-Stimulating Factor
Granulocyte-Macrophage Colony-Stimulating Factor
Coculture Techniques
Thymus Gland
Interleukin-6
Blood Cells
Stem Cells
Fibroblasts
Cytokines
T-Lymphocytes
Transplants
Liver
Genes
Neoplasms

ASJC Scopus subject areas

  • Cancer Research
  • Cell Biology
  • Genetics
  • Hematology
  • Oncology
  • Transplantation

Cite this

Humeau, L., Namikawa, R., Bardin, F., Maroc, C., Manonni, P., Roncarolo, M. G., & Chabannon, C. (1997). Phenotypical and functional characterizations of ex vivo manipulated cd34± progenitors from steady state and mobilized peripheral blood. Experimental Hematology, 25(8), 879.

Phenotypical and functional characterizations of ex vivo manipulated cd34± progenitors from steady state and mobilized peripheral blood. / Humeau, L.; Namikawa, R.; Bardin, F.; Maroc, C.; Manonni, P.; Roncarolo, M. G.; Chabannon, C.

In: Experimental Hematology, Vol. 25, No. 8, 1997, p. 879.

Research output: Contribution to journalArticle

Humeau, L, Namikawa, R, Bardin, F, Maroc, C, Manonni, P, Roncarolo, MG & Chabannon, C 1997, 'Phenotypical and functional characterizations of ex vivo manipulated cd34± progenitors from steady state and mobilized peripheral blood', Experimental Hematology, vol. 25, no. 8, pp. 879.
Humeau, L. ; Namikawa, R. ; Bardin, F. ; Maroc, C. ; Manonni, P. ; Roncarolo, M. G. ; Chabannon, C. / Phenotypical and functional characterizations of ex vivo manipulated cd34± progenitors from steady state and mobilized peripheral blood. In: Experimental Hematology. 1997 ; Vol. 25, No. 8. pp. 879.
@article{cf430235a5a4466aa5e8cfe911c07858,
title = "Phenotypical and functional characterizations of ex vivo manipulated cd34± progenitors from steady state and mobilized peripheral blood",
abstract = "Cytokine mobilized peripheral blood progenitor cells are widely used lor iranspl.ini.iiu'n in cancer patients because of easy collection and rapid h{\'e}matologie reconstitution These cells may be appropriate targets for gene transfer. Therefore, We investigated the effects of ex vivo manipulation on hematopoietic reconstitution potential of these cells. Immunoselected CD34± progenitors isolated from steady-state (ssCD34±) or G-CSF mobilized (mCD34±) peripheral blood were cultured for 5 days: 2-day liquid culture followed by 3-day coculture on A7.21, a rnurine fibroblast layer, in the presence of 10{\%} PCS, 1L-3, IL-6, GM-CSF, and KL. Higher levels of expansion in CD34± cells were observed in ssCD34± than in mCD34± cells (4.6±3.3- vs. 2.2±1.3-fold). Hematopoietic reconstitution potentials of these ex vivo manipulated cells were evaluated using the SCID-hu mouse models implanted with human fetal bone marrow (BM) or thymus/liver. Human BM analyzed 4 weeks after injection of manipulated ssCD34± cells showed reconstitution in CD19± (0.6-98.8{\%}), CD33± (2.8-99.3{\%}) and CD34± progenitor (2.4-17{\%}) cells (n=4); ihyinic grafts analyzed 6-8 weeks after injection also demonstrated high levels of T cells reconstitution (67.2-86.4{\%}) (n=4). In contrast, only very low levels of reconstitution (",
author = "L. Humeau and R. Namikawa and F. Bardin and C. Maroc and P. Manonni and Roncarolo, {M. G.} and C. Chabannon",
year = "1997",
language = "English",
volume = "25",
pages = "879",
journal = "Experimental Hematology",
issn = "0301-472X",
publisher = "Elsevier Inc.",
number = "8",

}

TY - JOUR

T1 - Phenotypical and functional characterizations of ex vivo manipulated cd34± progenitors from steady state and mobilized peripheral blood

AU - Humeau, L.

AU - Namikawa, R.

AU - Bardin, F.

AU - Maroc, C.

AU - Manonni, P.

AU - Roncarolo, M. G.

AU - Chabannon, C.

PY - 1997

Y1 - 1997

N2 - Cytokine mobilized peripheral blood progenitor cells are widely used lor iranspl.ini.iiu'n in cancer patients because of easy collection and rapid hématologie reconstitution These cells may be appropriate targets for gene transfer. Therefore, We investigated the effects of ex vivo manipulation on hematopoietic reconstitution potential of these cells. Immunoselected CD34± progenitors isolated from steady-state (ssCD34±) or G-CSF mobilized (mCD34±) peripheral blood were cultured for 5 days: 2-day liquid culture followed by 3-day coculture on A7.21, a rnurine fibroblast layer, in the presence of 10% PCS, 1L-3, IL-6, GM-CSF, and KL. Higher levels of expansion in CD34± cells were observed in ssCD34± than in mCD34± cells (4.6±3.3- vs. 2.2±1.3-fold). Hematopoietic reconstitution potentials of these ex vivo manipulated cells were evaluated using the SCID-hu mouse models implanted with human fetal bone marrow (BM) or thymus/liver. Human BM analyzed 4 weeks after injection of manipulated ssCD34± cells showed reconstitution in CD19± (0.6-98.8%), CD33± (2.8-99.3%) and CD34± progenitor (2.4-17%) cells (n=4); ihyinic grafts analyzed 6-8 weeks after injection also demonstrated high levels of T cells reconstitution (67.2-86.4%) (n=4). In contrast, only very low levels of reconstitution (

AB - Cytokine mobilized peripheral blood progenitor cells are widely used lor iranspl.ini.iiu'n in cancer patients because of easy collection and rapid hématologie reconstitution These cells may be appropriate targets for gene transfer. Therefore, We investigated the effects of ex vivo manipulation on hematopoietic reconstitution potential of these cells. Immunoselected CD34± progenitors isolated from steady-state (ssCD34±) or G-CSF mobilized (mCD34±) peripheral blood were cultured for 5 days: 2-day liquid culture followed by 3-day coculture on A7.21, a rnurine fibroblast layer, in the presence of 10% PCS, 1L-3, IL-6, GM-CSF, and KL. Higher levels of expansion in CD34± cells were observed in ssCD34± than in mCD34± cells (4.6±3.3- vs. 2.2±1.3-fold). Hematopoietic reconstitution potentials of these ex vivo manipulated cells were evaluated using the SCID-hu mouse models implanted with human fetal bone marrow (BM) or thymus/liver. Human BM analyzed 4 weeks after injection of manipulated ssCD34± cells showed reconstitution in CD19± (0.6-98.8%), CD33± (2.8-99.3%) and CD34± progenitor (2.4-17%) cells (n=4); ihyinic grafts analyzed 6-8 weeks after injection also demonstrated high levels of T cells reconstitution (67.2-86.4%) (n=4). In contrast, only very low levels of reconstitution (

UR - http://www.scopus.com/inward/record.url?scp=33748634370&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748634370&partnerID=8YFLogxK

M3 - Article

VL - 25

SP - 879

JO - Experimental Hematology

JF - Experimental Hematology

SN - 0301-472X

IS - 8

ER -